ES2044874T3 - Derivados del acido malonico y metodos para su sintesis. - Google Patents

Derivados del acido malonico y metodos para su sintesis.

Info

Publication number
ES2044874T3
ES2044874T3 ES87109317T ES87109317T ES2044874T3 ES 2044874 T3 ES2044874 T3 ES 2044874T3 ES 87109317 T ES87109317 T ES 87109317T ES 87109317 T ES87109317 T ES 87109317T ES 2044874 T3 ES2044874 T3 ES 2044874T3
Authority
ES
Spain
Prior art keywords
malonic acid
derivatives
cisteina
amino acids
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87109317T
Other languages
English (en)
Inventor
Trapani Romano Di
Antonio Silvio Verdini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sclavo SpA
Eni Tecnologie SpA
Original Assignee
Sclavo SpA
Eniricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo SpA, Eniricerche SpA filed Critical Sclavo SpA
Application granted granted Critical
Publication of ES2044874T3 publication Critical patent/ES2044874T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA NUEVA CLASE DE DERIVADOS DEL ACIDO MALONICO DE FORMULA GENERAL (I) EN LA QUE R1 Y R2, CADA UNA DE ELLAS INDEPENDIENTEMENTE, REPRESENTAN HIDROGENO O UN GRUPO PROTECTOR DEL CARBOXILO, Y EL RADICAL R CORRESPONDE A LA CADENA LATERAL DELOS AMINOACIDOS LISINA, ORNITINA, TIROSINA, CISTEINA, ACIDO ASPARTICO Y ACIDO GLUTAMICO, EN EL QUE LAS FUNCIONALIDADES ADICIONALES ESTAN ADECUADAMENTE PROTEGIDAS. LOS NUEVOS COMPUESTOS DE LA PRESENTE INVENCION SON UTILES PARA PREPARAR ANALOGOS DE PEPTIDOS BIOLOGICAMENTE ACTIVOS, EN LOS QUE HA SIDO INVERTIDA LA DIRECCION DE ALGUNOS ENLACES AMIDA EN LOS QUE INTERVIENEN LOS AMINOACIDOS LISINA, ORNITINA, TIROSINA, CISTEINA, ACIDO ASPARTICO O ACIDO GLUTAMICO.
ES87109317T 1986-07-16 1987-06-29 Derivados del acido malonico y metodos para su sintesis. Expired - Lifetime ES2044874T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21143/86A IT1196500B (it) 1986-07-16 1986-07-16 Derivati dell'acido malonico e metodi per la loro sintesi

Publications (1)

Publication Number Publication Date
ES2044874T3 true ES2044874T3 (es) 1994-01-16

Family

ID=11177375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87109317T Expired - Lifetime ES2044874T3 (es) 1986-07-16 1987-06-29 Derivados del acido malonico y metodos para su sintesis.

Country Status (8)

Country Link
US (1) US4914226A (es)
EP (1) EP0254080B1 (es)
JP (1) JPS6323834A (es)
AT (1) ATE86964T1 (es)
CA (1) CA1304539C (es)
DE (1) DE3784799T2 (es)
ES (1) ES2044874T3 (es)
IT (1) IT1196500B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02245277A (ja) * 1989-03-20 1990-10-01 Ntn Corp 圧電素子を用いた加振装置
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US6756379B2 (en) 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
US7683071B2 (en) * 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
US6939873B2 (en) * 2000-07-26 2005-09-06 Taro Pharmaceuticals Industries Limited Non-sedating barbituric acid derivatives
JP4739760B2 (ja) 2002-12-11 2011-08-03 タロー・ファーマシューティカル・インダストリーズ・リミテッド バルビツール酸誘導体を使用する運動障害の治療方法
WO2006003651A2 (en) * 2004-07-02 2006-01-12 Taro Pharmaceutical Industries, Ltd A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
EP2081576A4 (en) * 2006-11-14 2010-06-30 Taro Pharmaceuticals North Ame METHOD FOR IMPROVING BIOAVAILABILITY FOR NON-EDMING BARBITURATES
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US9279022B1 (en) 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
EP2630191A4 (en) 2010-10-20 2015-05-20 Sirrus Inc SYNTHESIS SUBSTANTIALLY CLEANING METHYLENE MALONATES
CA2853073A1 (en) 2011-10-19 2013-04-25 Bioformix Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US9181365B2 (en) 2012-03-30 2015-11-10 Sirrus, Inc. Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby
US9234107B2 (en) 2012-03-30 2016-01-12 Sirrus, Inc. Ink coating formulations and polymerizable systems for producing the same
US10913875B2 (en) 2012-03-30 2021-02-09 Sirrus, Inc. Composite and laminate articles and polymerizable systems for producing the same
US10047192B2 (en) 2012-06-01 2018-08-14 Sirrus, Inc. Optical material and articles formed therefrom
EP2920231B1 (en) 2012-11-16 2020-05-06 Sirrus, Inc. Plastics bonding systems and methods
CN105164797B (zh) 2012-11-30 2019-04-19 瑟拉斯公司 用于电子应用的复合组合物
WO2014110388A1 (en) 2013-01-11 2014-07-17 Bioformix Inc. Method to obtain methylene malonate via bis(hydroxymethyl) malonate pathway
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof
KR102943550B1 (ko) * 2019-09-26 2026-03-26 아지노모토 가부시키가이샤 유기 물질의 유도체의 제조방법 및 유기 물질을 포함하는 시료의 분석 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013069A (en) * 1958-07-15 1961-12-12 American Cyanamid Co 2-(substituted-benzyl)-1, 3-propane-dicarboxylic acids
AR194578A1 (es) * 1970-11-09 1973-07-31 Kendall & Co Un procedimiento para preparar acidos 5-sustituidos-5-fenilalquil barbituricos y un compuesto intermedio obtenido durante dicho procedimiento
FR2211007A5 (es) * 1972-12-15 1974-07-12 Ugine Kuhlmann
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
IT1190891B (it) * 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
CA1304539C (en) 1992-06-30
ATE86964T1 (de) 1993-04-15
IT1196500B (it) 1988-11-16
EP0254080A2 (en) 1988-01-27
EP0254080A3 (en) 1989-05-31
US4914226A (en) 1990-04-03
IT8621143A0 (it) 1986-07-16
JPS6323834A (ja) 1988-02-01
EP0254080B1 (en) 1993-03-17
DE3784799D1 (de) 1993-04-22
DE3784799T2 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
IT1196500B (it) Derivati dell'acido malonico e metodi per la loro sintesi
GT200000183A (es) Aminoacidos biciclicos como agentes farmaceuticos.
ES2085271T3 (es) Nuevos derivados de insulina, procedimiento para su preparacion, su utilizacion y preparado farmaceutico que los contiene.
ES8106134A1 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos
ES8701196A1 (es) Un procedimiento para la preparacion de dipeptidos derivados de tiazolina.
ES2151185T3 (es) Lipopoliaminas como agentes de transfeccion y sus aplicaciones farmaceuticas.
ES8401937A1 (es) Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
ES472742A1 (es) Procedimiento para la obtencion de derivados de alqueno
ES2064310T3 (es) Procedimiento para preparar compuestos de imidazopiridina.
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ES521655A0 (es) Procedimiento para la preparacion de aminoacidos ciclicos o esteres de los mismos.
ES2065369T3 (es) Uso de bencimidazoles en el tratamiento de enfermedades epiteliales.
ES2159734T3 (es) Derivados 2-heteroarilalquenilicos del acido ciclopentano-heptan(en)oico como agentes terapeuticos para el tratamiento de la hipertension ocular.
ES2194319T3 (es) Derivados de aminoacidos inhibidores de las metaloproteasas de la matriz extracelular y de la liberacion del tnf alfa.
ES2108772T3 (es) Derivados de aminofosfonato substituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9301197A (es) Derivados de indol.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
MX9302327A (es) Aminoacidos ciclicos novedosos y derivados de los mismos.
ES2160790T3 (es) 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2098866T3 (es) Oligodesoxirribonucleotidos modificados, su preparacion y su utilizacion terapeutica.
MX9303933A (es) Compuestos intermedios sinteticos novedosos y procedimiento para la preparacion de los derivados de los aminoacidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254080

Country of ref document: ES